UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 18, 2016 4:30 P.M.

Form:	S-1
CIK: 0001674416 Company Name: CRISPR Therapeutics AG File Number: 333-213577